Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Frexalimab

😃Good
Catalog No. T77013Cas No. 2515463-86-0
Alias SAR-441344, SAR441344, INX-021, INX021

Frexalimab (SAR441344) is a second-generation humanized monoclonal antibody targeting CD40L. It blocks the CD40/CD40L signaling pathway to reduce inflammation and tissue damage, making it applicable for autoimmune diseases such as primary Sjögren's syndrome, systemic lupus erythematosus, and multiple sclerosis.

Frexalimab

Frexalimab

😃Good
Purity: 95%
Catalog No. T77013Alias SAR-441344, SAR441344, INX-021, INX021Cas No. 2515463-86-0
Frexalimab (SAR441344) is a second-generation humanized monoclonal antibody targeting CD40L. It blocks the CD40/CD40L signaling pathway to reduce inflammation and tissue damage, making it applicable for autoimmune diseases such as primary Sjögren's syndrome, systemic lupus erythematosus, and multiple sclerosis.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$328-In Stock
5 mg$859-In Stock
10 mg$1,380-In Stock
25 mg$1,980-In Stock
50 mg$2,760-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:95%
Contact us for more batch information

Product Introduction

Bioactivity
Description
Frexalimab (SAR441344) is a second-generation humanized monoclonal antibody targeting CD40L. It blocks the CD40/CD40L signaling pathway to reduce inflammation and tissue damage, making it applicable for autoimmune diseases such as primary Sjögren's syndrome, systemic lupus erythematosus, and multiple sclerosis.
In vitro
Frexalimab is a second-generation Fc-modified humanized monoclonal antibody against CD40L, whose Fc modification eliminates platelet activation triggered by immune complex stimulation of FcγRIIa [2].
SynonymsSAR-441344, SAR441344, INX-021, INX021
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
Endotoxin< 1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetCD40
Chemical Properties
Cas No.2515463-86-0
ColorTransparent
AppearanceLiquid
Antibody Information
IsotypeIgG1-ARA
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Frexalimab | purchase Frexalimab | Frexalimab cost | order Frexalimab | Frexalimab in vitro